Grateful to @PCORI for supporting this exciting trial comparing safety-net abx prescribing vs immediate Rx in kids with mild pneumonia w/ coPI @JulieSzymczak & coIs @nkuppermann, @jeffreysgerber, @AlexGFiks, @UtahDCC. @LuriePEM, @NUFeinbergMed, @nu_ipham, @ClinFuturesCHOP
.@LurieChildrens awarded $12 million from @PCORI to research the best treatment strategy for mild #pneumonia in kids 1 to 6 years of age. luriechildrens.org/en/news-storie… @NUFeinbergMed @toddflorin1 #pediatrics #researchView quoted post on X